Intrinsic Value of S&P & Nasdaq Contact Us

Atea Pharmaceuticals, Inc. AVIR NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
47/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$6.88
+18.6%

Atea Pharmaceuticals, Inc. (AVIR) has 10 identified peers for comparison in the Healthcare sector. Peers include AVRO, CNSP, CWBR, EFTR, ELEV, ENVB and others.

AVIR has a market capitalization of $462.1M, compared to an average peer market cap of $58.15M. AVIR is significantly larger than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message